CRDL · Cardiol Therapeutics Inc.
Market Cap
$226.64M
Shares
116.82M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
78.76K
FY2021
Net Income
-33.82M
+7.8%
FY2025
Operating Margin
-49091.93%
FY2021
Operating Cash Flow
-23.85M
+4.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| CAD | — | — | — | — | 78.76K | — |
| CAD | 14.02M | 14.01M | 14.22M | 18.96M | 10.87M | 10.6M |
| CAD | 20.3M | 26.26M | 15.56M | 22.37M | 27.87M | 10.09M |
| CAD | 101.98K | 162.76K | 163.91K | 135.46K | 135.98K | 145.1K |
| CAD | -34.32M | -40.28M | -29.79M | -41.34M | -38.66M | -20.69M |
| CAD | — | — | — | 0 | 0 | 0 |
| CAD | -33.82M | -36.68M | -28.13M | -30.93M | -31.64M | -20.64M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Key facts
CIK
1702123
CUSIP
14161Y200
13F (30d)
40 filings
39 filers
Visit website
Investor relations